These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of plaque burden on coronary vasoreactivity in early atherosclerosis. Manginas A; Voudris V; Pavlides G; Karatasakis G; Athanassopoulos G; Cokkinos DV Am J Cardiol; 1998 Feb; 81(4):401-6. PubMed ID: 9485127 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease. Hung OY; Molony D; Corban MT; Rasoul-Arzrumly E; Maynard C; Eshtehardi P; Dhawan S; Timmins LH; Piccinelli M; Ahn SG; Gogas BD; McDaniel MC; Quyyumi AA; Giddens DP; Samady H J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811165 [TBL] [Abstract][Full Text] [Related]
26. The presence of African American race predicts improvement in coronary endothelial function after supplementary L-arginine. Houghton JL; Philbin EF; Strogatz DS; Torosoff MT; Fein SA; Kuhner PA; Smith VE; Carr AA J Am Coll Cardiol; 2002 Apr; 39(8):1314-22. PubMed ID: 11955849 [TBL] [Abstract][Full Text] [Related]
27. Role of nitric oxide in coronary vasomotion during handgrip exercise. Nishikawa Y; Kanki H; Ogawa S Am Heart J; 1997 Nov; 134(5 Pt 1):967-73. PubMed ID: 9398111 [TBL] [Abstract][Full Text] [Related]
28. Assessment of endothelial function using peripheral waveform analysis: a clinical application. Hayward CS; Kraidly M; Webb CM; Collins P J Am Coll Cardiol; 2002 Aug; 40(3):521-8. PubMed ID: 12142121 [TBL] [Abstract][Full Text] [Related]
29. Acute effects of 17 beta-estradiol on the coronary microcirculation: observations in sedated, closed-chest domestic swine. Berman M; Gewirtz H Coron Artery Dis; 1997 Jun; 8(6):351-61. PubMed ID: 9347215 [TBL] [Abstract][Full Text] [Related]
30. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Newby DE; McLeod AL; Uren NG; Flint L; Ludlam CA; Webb DJ; Fox KA; Boon NA Circulation; 2001 Apr; 103(15):1936-41. PubMed ID: 11306520 [TBL] [Abstract][Full Text] [Related]
31. Anatomic and physiologic heterogeneity in patients with syndrome X: an intravascular ultrasound study. Wiedermann JG; Schwartz A; Apfelbaum M J Am Coll Cardiol; 1995 May; 25(6):1310-7. PubMed ID: 7722126 [TBL] [Abstract][Full Text] [Related]
32. Salbutamol-induced Decrease in Augmentation Index is Related to the Parallel Increase in Heart Rate. Tikkakoski AJ; Kangas P; Suojanen L; Tahvanainen AM; Eräranta A; Kähönen MAP; Sipilä K; Mustonen JT; Pörsti IH Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):161-173. PubMed ID: 29476697 [TBL] [Abstract][Full Text] [Related]
33. Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P. Tousoulis D; Tentolouris C; Crake T; Katsimaglis G; Stefanadis C; Toutouzas P; Davies GJ Heart; 1999 May; 81(5):505-11. PubMed ID: 10212169 [TBL] [Abstract][Full Text] [Related]
34. Relation of Basal coronary nitric oxide activity to the burden of atherosclerosis. Anderson TJ; Worthley MI; Goodhart DM; Curtis MJ Am J Cardiol; 2005 May; 95(10):1170-4. PubMed ID: 15877988 [TBL] [Abstract][Full Text] [Related]
35. Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris. Watanabe K; Ikeda S; Komatsu J; Inaba S; Suzuki J; Sueda S; Funada J; Kitakaze M; Sekiya M Am J Cardiol; 2003 Jul; 92(1):21-5. PubMed ID: 12842239 [TBL] [Abstract][Full Text] [Related]
36. L-arginine ameliorates the abnormal sympathetic response of the dysfunctional human coronary microvasculature. Gellman J; Hare JM; Lowenstein CJ; Gerstenblith G; Coombs V; Langenberg P; Brinker JA; Resar JR Angiology; 2004; 55(1):1-8. PubMed ID: 14759083 [TBL] [Abstract][Full Text] [Related]
37. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Kugiyama K; Doi H; Motoyama T; Soejima H; Misumi K; Kawano H; Nakagawa O; Yoshimura M; Ogawa H; Matsumura T; Sugiyama S; Nakano T; Nakajima K; Yasue H Circulation; 1998 Jun; 97(25):2519-26. PubMed ID: 9657472 [TBL] [Abstract][Full Text] [Related]
38. Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque. Tousoulis D; Davies GJ; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P Heart; 2001 Sep; 86(3):296-301. PubMed ID: 11514482 [TBL] [Abstract][Full Text] [Related]
39. Influence of differential vascular remodeling on the coronary vasomotor response. McLeod AL; Newby DE; Northridge DB; Fox KA; Uren NG Cardiovasc Res; 2003 Aug; 59(2):520-6. PubMed ID: 12909335 [TBL] [Abstract][Full Text] [Related]
40. Investigation of endothelial function by pulse contour analysis: a protocol for drug administration and timing of pulse contour assessment. Gordon SE; Cartwright N; Griffiths MJ Br J Clin Pharmacol; 2009 Oct; 68(4):630-3. PubMed ID: 19843066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]